No link between TGFBR1 gene expression and colorectal cancer risk
Author Information
Author(s): Seguí N, Stevens K N, Guinó E, Rozek L S, Moreno V R, Capellá G, Gruber S B, Valle L
Primary Institution: Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL
Hypothesis
Does germline allele-specific expression of TGFBR1 increase the risk of colorectal cancer in Caucasian and Ashkenazi populations?
Conclusion
The study found that allele-specific expression of TGFBR1 does not increase the risk of colorectal cancer.
Supporting Evidence
- Allele-specific expression was measured in 426 Ashkenazi Jewish CRC patients and 433 controls.
- No significant differences in allele-specific expression were found between cases and controls.
- 1.0% of CRC patients and 2.2% of controls showed allele-specific expression of TGFBR1.
Takeaway
The study looked at a gene called TGFBR1 to see if it makes people more likely to get colon cancer, but it turns out it doesn't.
Methodology
The study measured allele-specific expression using pyrosequencing in two populations: Ashkenazi Jewish and Caucasian.
Limitations
The study's findings may be limited by the sample size and the specific populations studied.
Participant Demographics
Participants included 426 Ashkenazi Jewish colorectal cancer patients and 433 matched controls.
Statistical Information
P-Value
0.52
Confidence Interval
95% CI: -0.027 to 0.032
Statistical Significance
p=0.52
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website